Bodytrak® is unique. It exploits the only body site from which all vital signs can be measured. From one small non-invasive, in-ear device, metrics including core body temperature, heart rate, VO2 and motion (speed, distance, cadence) are sent wirelessly to the user in real-time via a smart phone, smart watch or internet hub. Since Bodytrak® accesses the ear, it detects changes in body physiology rapidly and accurately due to its close proximity to the brain, more effectively than when measuring at the periphery of the body. Machine learning algorithms enable early intervention to improve outcomes and reduce injury and associated insurance premiums. By utilising miniature components, Bodytrak® also provides two-way communications, music playback and ambient sound transparency to meet the different needs of the sport, defence, first response, health and safety, and healthcare markets. Bodytrak® has been gold-standard tested by leading universities, and we have over 40 trial partners across all target markets. We also have a growing patent portfolio as well as significant value in our proprietary analytics.

Bodytrak® is unique. It exploits the only body site from which all vital signs can be measured. From one small non-invasive, in-ear device, metrics including core body temperature, heart rate, VO2 and motion (speed, distance, cadence) are sent wirelessly to the user in real-time via a smart phone, smart watch or internet hub. Since Bodytrak® accesses the ear, it detects changes in body physiology rapidly and accurately due to its close proximity to the brain, more effectively than when measuring at the periphery of the body. Machine learning algorithms enable early intervention to improve outcomes and reduce injury and associated insurance premiums. By utilising miniature components, Bodytrak® also provides two-way communications, music playback and ambient sound transparency to meet the different needs of the sport, defence, first response, health and safety, and healthcare markets. Bodytrak® has been gold-standard tested by leading universities, and we have over 40 trial partners across all target markets. We also have a growing patent portfolio as well as significant value in our proprietary analytics.